Skip to content

RIVERBRIDGE PARTNERS LLC: CERT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of RIVERBRIDGE PARTNERS LLC on CERT, newest first. How the timeline and the estimate are built.

RIVERBRIDGE PARTNERS LLC held 0 CERT shares at 2025-09-30 per its 13F-HR filed 2025-10-14.

the latest 13F is the newest step

  1. period ended2025-09-30
    13F 0 shares
    Change vs previous 13F -43,741 shares

    13F-HR 0001112325-25-000016 filed by RIVERBRIDGE PARTNERS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-06-30
    13F 43,741 shares
    Change vs previous 13F -2,004,778 shares

    0.01% of the 13F portfolio, value $511,768.

    13F-HR 0001112325-25-000012 filed by RIVERBRIDGE PARTNERS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 2,048,519 shares
    Change vs previous 13F -116,228 shares

    0.33% of the 13F portfolio, value $20,280,338.

    13F-HR 0001112325-25-000009 filed by RIVERBRIDGE PARTNERS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 2,164,747 shares
    Change vs previous 13F -236,171 shares

    0.31% of the 13F portfolio, value $23,054,554.

    13F-HR 0001112325-25-000005 filed by RIVERBRIDGE PARTNERS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 2,400,918 shares
    Change vs previous 13F not available

    0.38% of the 13F portfolio, value $28,114,745.

    13F-HR 0001112325-24-000010 filed by RIVERBRIDGE PARTNERS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).